Aurélien Millet

Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA.

F. Goldwasser, J. Guitton, Pauline Bros, 2020, Talanta.

Determination of Cetuximab in Plasma by Liquid Chromatography-High-Resolution Mass Spectrometry Orbitrap With a Stable Labeled 13C,15N-Cetuximab Internal Standard.

J. Guitton, P. Céruse, B. You, 2019, Therapeutic drug monitoring.

Quantification of canakinumab in human plasma by liquid chromatography-high resolution mass spectrometry.

J. Guitton, A. Belot, C. Machon, 2022, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Pre-referral intranasal artesunate powder for cerebral malaria: a proof-of-concept study

A. Bienvenu, S. Picot, Guillaume Bonnot, 2022, Malaria Journal.

Potential interference of hydroxychloroquine-glucuronide metabolite on therapeutic drug monitoring of hydroxychloroquine using a mass spectrometry detector

J. Guitton, F. Parant, M. Gagnieu, 2020, Clinical chemistry and laboratory medicine.

Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study

J. Guitton, B. Lacarelle, J. Ciccolini, 2021, Pharmaceuticals.

An approach for interlaboratory comparison of conventional and real-time PCR assays for diagnosis of human leishmaniasis.

M. Chenik, I. Cruz, P. Salotra, 2013, Experimental parasitology.

Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma

J. Guitton, B. Terrier, N. Khoudour, 2021, Molecules.

Analysis of Pembrolizumab in Human Plasma by LC-MS/HRMS. Method Validation and Comparison with Elisa

F. Goldwasser, J. Guitton, N. Khoudour, 2021, Biomedicines.

An approach for interlaboratory comparison of conventional and real-time PCR assays for diagnosis of human leishmaniasis.

M. Chenik, I. Cruz, P. Salotra, 2013, Experimental parasitology.